Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (311-320 of 357) with videos related to

Pageof 36
Sort By:
Neuropathology and Applied Neurobiology|November 7, 2006
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumoursS Long, D J Argyle, C Nixon, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategiesR I Nicholson, I R Hutcheson, D Britton, et al.
British Journal of Cancer|January 1, 1987
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 casesM R Williams, J H Todd, I O Ellis, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibitionJoan Albanell, Federico Rojo, Steve Averbuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combinationRobert I Nicholson, Iain R Hutcheson, Janice M Knowlden, et al.
Endocrine-Related Cancer|December 23, 2004
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsH E Jones, L Goddard, J M W Gee, et al.
Nature|November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenAntoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Endocrine-Related Cancer|September 22, 2001
Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.
Pageof 36

Showing results (311-320 of 357) with videos related to

Sort By:
Pageof 36
Neuropathology and Applied Neurobiology|November 7, 2006
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumoursS Long, D J Argyle, C Nixon, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategiesR I Nicholson, I R Hutcheson, D Britton, et al.
British Journal of Cancer|January 1, 1987
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 casesM R Williams, J H Todd, I O Ellis, et al.
International Journal of Cancer|October 31, 2000
Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expressionS S Yip, A J Crew, J M Gee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibitionJoan Albanell, Federico Rojo, Steve Averbuch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combinationRobert I Nicholson, Iain R Hutcheson, Janice M Knowlden, et al.
Endocrine-Related Cancer|December 23, 2004
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cellsH E Jones, L Goddard, J M W Gee, et al.
Nature|November 14, 2008
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifenAntoni Hurtado, Kelly A Holmes, Timothy R Geistlinger, et al.
Endocrine-Related Cancer|September 22, 2001
Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.
Annals of the New York Academy of Sciences|July 4, 2002
Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancerR I Nicholson, I R Hutcheson, M E Harper, et al.
Pageof 36